CORP — CORPORATE / INDUSTRY

Astellas ISR & General Research Grants

Astellas

Award

Funding/compound (ISR); registry & network grants (GRG)

Deadline

Rolling (Japan: Oct–Nov window)

Award type

Cash grant

Focus

Clinical research · Registries & biomarkers

Astellas funds investigator-sponsored research, and its General Research Grants also cover registries, networks, and reviews.

Why it's in this index

Mitochondria is one of Astellas' declared primary R&D focus areas — via legacy Mitobridge, ASP0367 for primary mitochondrial myopathy, and a mitochondrial cell-therapy deal with Minovia — which gives mitochondrial-disease proposals an explicit area to align with. That makes this a stronger fit than most pharma ISR routes.

Who can apply

Researchers, physicians, academic institutions, and consortia as study sponsors; compound-specific areas of interest are listed on the portal.

How to apply

ISR proposals via the external funding pages, rolling (Japan runs an October–November window); General Research Grants via regional grants offices.

Links & downloads

Astellas external funding ↗